IMC
VRTX icon

Investment Management Corporation’s Vertex Pharmaceuticals VRTX Stock Holding History

Investment Management Corporation’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,064
Closed -$475K – 56
2026
Q1 		$475K Buy
1,064
+21
+2% +$9.79K 0.41% 47
2025
Q4 		$473K Buy
1,043
+16
+2% +$6.9K 0.4% 49
2025
Q3 		$402K Buy
1,027
+21
+2% +$8.78K 0.35% 48
2025
Q2 		$448K Buy
1,006
+14
+1% +$6.45K 0.41% 47
2025
Q1 		$481K Buy
992
+154
+18% +$71.8K 0.43% 42
2024
Q4 		$337K Buy
+838
New +$388K 0.3% 46

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Investment Management Corporation's VRTX Position: Q2 2026 in Review

Investment Management Corporation sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 1,064 shares — an estimated $475K sold.

Investment Management Corporation first reported a position in VRTX in Q4 2024 and held it in 6 quarters. The position peaked at $481K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Investment Management Corporation reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Investment Management Corporation sold 1,064 Vertex Pharmaceuticals shares in Q2 2026, an estimated $475K.
  • Investment Management Corporation first reported a position in Vertex Pharmaceuticals in Q4 2024 and held it in 6 quarters.
  • Investment Management Corporation's Vertex Pharmaceuticals position peaked at $481K in Q1 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Investment Management Corporation's 13F filing for Q2 2026, filed 22 Jul 2026.